Glibenclamide vs acarbose ‐ maternal outcomes
Caesarean section · women diagnosed with gestational diabetes; 11 to 33 weeks' gestation; singleton pregnancy
Glibenclamide showed no clear difference in caesarean section compared with acarbose ‐ maternal outcomes (low certainty).
1 finding from 1 review
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes onlyRR 0.95 [0.53, 1.7]1 study · 43 participantsLow